Literature DB >> 11762953

Increased resistance to collagen-induced arthritis in CD44-deficient DBA/1 mice.

R Stoop1, H Kotani, J D McNeish, I G Otterness, K Mikecz.   

Abstract

OBJECTIVE: To study the role of CD44, the principal hyaluronan (HA) receptor, in experimental arthritis.
METHODS: We generated CD44 gene deficiency in arthritis-susceptible DBA/1LacJ mice to study the role of CD44 directly in collagen-induced arthritis (CIA). Wild-type and CD44-deficient mice were immunized with chicken type II collagen, and the onset and severity of CIA were monitored up to day 64. The immune status of immunized mice was determined at the end of the experiments. Cell transfer experiments were performed to monitor lymphocyte traffic to the inflamed joints.
RESULTS: Mice homozygous for the CD44 mutation developed normally and showed no phenotypic defects. Although they showed a normal response to immunization with type II collagen and had Th1/Th2 ratios comparable with those in wild-type animals, CD44-deficient mice exhibited significant reductions in both the incidence and severity of CIA. This was accompanied by altered serum levels of HA, reduced expression of L-selectin, and a delayed entry of intravenously injected CD44-deficient donor lymphocytes into the arthritic joints of recipient mice.
CONCLUSION: While CD44 is not essential for morphogenesis and autoimmunity, this cell surface receptor seems to play an important role in the development of arthritis, most likely by directing leukocyte traffic to the site of inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11762953     DOI: 10.1002/1529-0131(200112)44:12<2922::aid-art480>3.0.co;2-7

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

1.  CD44 mobilization in allogeneic dendritic cell-T cell immunological synapse plays a key role in T cell activation.

Authors:  Venkatesh L Hegde; Narendra P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Leukoc Biol       Date:  2008-04-03       Impact factor: 4.962

2.  Small changes in lymphocyte development and activation in mice through tissue-specific alteration of heparan sulphate.

Authors:  Omai B Garner; Yu Yamaguchi; Jeffrey D Esko; Vibeke Videm
Journal:  Immunology       Date:  2008-05-09       Impact factor: 7.397

3.  RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy.

Authors:  Shlomo Nedvetzki; Erez Gonen; Nathalie Assayag; Reuven Reich; Richard O Williams; Robin L Thurmond; Jing-Feng Huang; Birgit A Neudecker; Fu-Sheng Wang; Fu-Shang Wang; Eva A Turley; David Naor
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-13       Impact factor: 11.205

Review 4.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

5.  CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis.

Authors:  Gábor Hutás; Eva Bajnok; István Gál; Alison Finnegan; Tibor T Glant; Katalin Mikecz
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

6.  Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.

Authors:  Adrienn Angyal; Colt Egelston; Tamás Kobezda; Katalin Olasz; Anna László; Tibor T Glant; Katalin Mikecz
Journal:  Arthritis Res Ther       Date:  2010-03-18       Impact factor: 5.156

7.  CD44 deficiency improves healing tendon mechanics and increases matrix and cytokine expression in a mouse patellar tendon injury model.

Authors:  Heather L Ansorge; Pedro K Beredjiklian; Louis J Soslowsky
Journal:  J Orthop Res       Date:  2009-10       Impact factor: 3.494

8.  Tumor necrosis factor-stimulated gene-6 (TSG-6) amplifies hyaluronan synthesis by airway smooth muscle cells.

Authors:  Mark E Lauer; Georgiana Cheng; Shadi Swaidani; Mark A Aronica; Paul H Weigel; Vincent C Hascall
Journal:  J Biol Chem       Date:  2012-11-05       Impact factor: 5.157

Review 9.  Hyaluronan as a therapeutic target in human diseases.

Authors:  Jiurong Liang; Dianhua Jiang; Paul W Noble
Journal:  Adv Drug Deliv Rev       Date:  2015-11-02       Impact factor: 15.470

10.  The role of CD44 in cutaneous inflammation.

Authors:  Mona Man; Peter M Elias; Wenyan Man; Yan Wu; Lilly Y W Bourguignon; Kenneth R Feingold; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2009-03-26       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.